Suppression of human monocyte interleukin-1β production by ajulemic acid, a nonpsychoactive cannabinoid
- 1 February 2003
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 65 (4) , 649-655
- https://doi.org/10.1016/s0006-2952(02)01604-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- TNF and receptors in organ-specific autoimmune disease: multi-layered functioning mirrored in animal modelsJournal of Clinical Investigation, 2001
- Severe inflammatory arthritis and lymphadenopathy in the absence of TNFJournal of Clinical Investigation, 2001
- The Cannabinoid AcidsPharmacology & Therapeutics, 1999
- Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of AdenylylcyclaseJournal of Medicinal Chemistry, 1997
- Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritisArthritis & Rheumatism, 1995
- Δ9-tetrahydrocannabinol (THC) modulates IL-1 bioactivity in human monocyte/macrophage cell linesLife Sciences, 1994
- Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activitiesJournal of Medicinal Chemistry, 1992
- Further studies on the antinociceptive effects ofΔ acidInflammation Research, 1990
- Cannabinoids. Structure-activity studies related to 1,2-dimethylheptyl derivativesJournal of Medicinal Chemistry, 1973
- Isolation and Characterization of Two Major Urinary Metabolites of Δ 1 -TetrahydrocannabinolScience, 1972